XML 60 R51.htm IDEA: XBRL DOCUMENT v3.25.3

Derivative Financial Instruments - Schedule of Sales (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2025	Oct. 31, 2024	Oct. 31, 2025	Oct. 31, 2024
Schedule Of Sales Abstract
Net sales	$ (328)	$ 300	$ (110)	$ 737
Cost of sales	$ 1,878	$ 3,753	$ 4,163	$ (2,362)

X

- Definition

Cost of sales

+ References

No definition available.

+ Details

Name:	rex_GainLossOnDerivativeInstrumentsCostOfSales
Namespace Prefix:	rex_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	rex_ScheduleOfSalesAbstract
Namespace Prefix:	rex_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A

+ Details

Name:	us-gaap_GainLossOnDerivativeInstrumentsNetPretax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration